Soft tissue infections caused by spore-forming bacteria in injecting drug users in the United Kingdom

Epidemiology and Infection

Volumn 133, Issue 4, 2005, Pages 575-582

  Brett, M M ^a   Hood, J ^b   Brazier, J S ^c   Duerden, B I ^d   Hahne S J M ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b GLASGOW ROYAL INFIRMARY   (United Kingdom)

^c UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^d CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTITOXIN; CLINDAMYCIN; DIAMORPHINE; DICLOXACILLIN; DIPHTHERIA VACCINE; METRONIDAZOLE; NEUROTOXIN; PENICILLIN G; TETANUS ANTIBODY; TETANUS TOXOID; VIRULENCE FACTOR;

BACILLUS ANTHRACIS; BACILLUS CEREUS; BACTERIAL VIRULENCE; BOTULISM; CLINICAL FEATURE; CLINICAL PROTOCOL; CLOSTRIDIUM BOTULINUM; CLOSTRIDIUM HISTOLYTICUM; CLOSTRIDIUM SORDELLII; CLOSTRIDIUM TETANI; DEBRIDEMENT; DISEASE SEVERITY; DRUG USE; HUMAN; INFECTION PREVENTION; LABORATORY TEST; NONHUMAN; PATHOGENESIS; PREVALENCE; REVIEW; RISK FACTOR; SOFT TISSUE INFECTION; TETANUS; TETANUS PROPHYLAXIS; UNITED KINGDOM;

AGE DISTRIBUTION; ANTI-BACTERIAL AGENTS; CLOSTRIDIUM; CLOSTRIDIUM INFECTIONS; DRUG RESISTANCE, BACTERIAL; FEMALE; FOLLOW-UP STUDIES; GREAT BRITAIN; HUMANS; INCIDENCE; MALE; MICROBIAL SENSITIVITY TESTS; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; SOFT TISSUE INFECTIONS; SPORES, BACTERIAL; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 22544447113     PISSN: 09502688     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0950268805003845     Document Type: Review

References (46)

1. Schoener EP, Hopper JA, Pierre JD. Injection drug use in North America. Infect Dis Clin N Am 2002; 16: 535-551.
2. Murphy EL, DeVita D, Liu H, Leung P, Ciccarone DH, Edlin BR. Risk factors for skin and soft tissue abscesses among injection drug users: a case-control study. Clin Infect Dis 2001; 33: 35-40.
3. Ebright JR, Pieper B. Skin and soft tissue infections in injection drug users. Infect Dis Clin N Am 2002; 16: 697-712.
4. MacLennan JD. The histotoxic clostridial infections of man. Bacteriol Rev 1962; 26: 177-274.
5. Hinchcliffe CE, Thornton GF. Bacillus bacteremia in an intravenous drug abuser. Conn Med 1987; 51: 362-365.
6. Weller PF, Nicholson A, Braslow N. The spectrum of Bacillus bacteremias in heroin addicts. Arch Intern Med 1979: 139: 293-294.
7. Dancer SJ, McNair D, Finn P, Kolsto A-B. Bacillus cereus cellulitis from contaminated heroin. J Med Microbiol 2002: 51: 278-281.
8. McLauchlin J, Mithani V, Bolton FJ, et al. An investigation into the microflora of heroin. J Med Microbiol 2002; 51: 1001-1008.
9. Brett MM, Hallas G, Mpamugo O. Wound botulism in the UK and Ireland. J Med Microbiol 2004; 53: 555-561.
10. Graham CA, McNaughton GW, Crawford R. 'Popping': a cause of soft tissue sepsis in chronic drug abusers. Eur J Emerg Med 1999; 6: 259-261.
11. Brazier JS, Morris TE, Duerden BI. Heat and acid tolerance of Clostridium novyi spores and their survival prior to preparation of heroin for injection. Anaerobe 2003: 9: 141-144.
12. Witcome M, Newton K, Jameson K, et al. Development of in vitro assays for the detection of botulinum toxins in foods. FEMS Immunol Med Microbiol 1999; 24: 319-323.
13. Schiavo G, Benfenati F, Poulain B, et al. Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin. Nature 1992; 359: 832-835.
14. von Eichel-Streiber C, Boquet P, Saureborn M, Thelestam TM. Large clostridial cytotoxins - a family of glycosyltransferases modifying small GTP-binding proteins. Trends Microbiol 1996; 4: 375-382.
15. Sneath PHNA, Mair NS, Sharpe ME, Holt JG, eds. Bergey's manual of systematic bacteriology, vol. 2. Baltimore: Williams and Wilkins Baltimore; 1986: 1141-1199.
16. Stevens DL. The pathogenesis of clostridial myonecrosis. Int J Med Microbiol 2000; 290: 497-502.
17. 2 in rabbit erythrocyte membranes by a novel hemolytic toxin (H-toxin) of Clostridium septicum. FEMS Microbiol Lett 1990; 68: 319-322.
18. Just I, Schallehn G, Aktories K. ADP-ribosylation of small GTP-binding proteins by Bacillus cereus. Biochem Biophys Res Commun 1992; 183: 931-936.
19. Sakurai N, Koike KA, Irie Y, Hayashi H. The rice culture filtrate of Bacillus cereus isolated from emetic-type food poisoning causes mitochondrial swelling in a HEp-2 cell. Microbiol Immunol 1994; 38: 337-343.
20. Werner AB, Passaro D, McGee J, Schecter R, Vugia DJ. Wound botulism in California, 1951-1988: Recent epidemic in heroin injectors. Commun Infect Dis 2000; 31: 1018-1024.
21. Kudrow DB, Henry DA, Haake DA, Marshall G, Mathisen GE. Botulism associated with Clostridium botulinum sinusitis after intranasal cocaine abuse. Ann Intern Med 1988; 109: 984-985.
22. Athwal BS, Gale AN, Brett MM, Youl BD. Wound botulism in the UK. Lancet 2001; 357: 234.
23. Hood J, Home G, Baird K, Sweeney G. Third UK case of wound botulism in an injecting drug user. SCIEH Wkly Rep 2000; 34: 200.
24. Mulleague L, Bonner SM, Samuel A, Nichols P, Shaw S, Gruning T. Wound botulism in drug addicts in the United Kingdom. Anaesthesia 2000; 56: 120-123.
25. Merrison AFA, Chidley KE, Dunnett J, Sieradzn P. Wound botulism associated with subcutaneous drug use. Br Med J 2002; 325: 1105-1110.
26. Jensenius M, Lovstad RZ, Dhaenens G, Rorvik LM. A heroin user with a wobbly head. Lancet 2000; 356: 1160.
27. Tacket CO, Shandera WX, Mann JM, Hargrett NT, Blake PA. Equine antitoxin use and other factors that predict outcome in foodborne botulism. Am J Med 1967; 42: 208-219.
28. Beller M, Middaugh JP. Repeated type E botulism in an Alaskan Eskimo. N Engl J Med 1990; 322: 855.
29. Norman B. Tetanus after hypodermic injection of morphia. Lancet 1876; ii: 873.
30. Rushdy AA, White JM, Ramsay ME, Crowcroft NS. Tetanus in England and Wales, 1984-2000. Epidemiol Infect 2003; 130: 71-77.
31. HPA. Cluster of cases of tetanus in injecting drug users in England. HPA COVER programme: April to June 2003. Commun Dis Rep CDR Wkly [serial online] 2003; 13 (http://www.hpa.org.uk/cdr/PDFfiles/2003/cdr3903.pdf). Accessed 23 Nov. 2003.
32. Cherubin C. Urban tetanus: the epidemiologic aspects of Tetanus in narcotics addicts in New York City. Arch Environ Health 1967; 14: 802-808.
33. Anon. Tetanus-United States, 1985-1986. MMWR 1987; 36: 477-481.
34. Anon. Tetanus surveillance - United States 1998-2000. MMWR 2003; 52: 1-8.
35. O'Malley CD, White E, Schecter R, Smith NJ, Waterman SH. Tetanus amongst injecting drug users - California, 1997. MMWR Wkly 1998; 47: 149-151.
36. Cherubin CE. Epidemiology of tetanus in narcotics addicts. NY State J Med 1970; 70: 267-271.
37. Tunkel AR, SK Pradhan. Central nervous system infections in injection drug users. Infect Dis Clin N Am 2002; 16: 589-605.
38. McGuiggan CC, Penrice GM, Gruer L, et al. Lethal outbreak of infection with Clostridium novyi type A and other spore-forming organisms in Scottish injecting drug users. J Med Microbiol 2002; 51: 971-977.
39. Jones JA, Salmon JE, Djuretic T, et al. An outbreak of serious illness and death among injecting drug users in England during 2000. J Med Microbiol 2002; 51: 978-984.
40. Noone M, Tabaqachi M, Spillane JB. Clostridium novyi causing necrotising fasciitis in an injecting drug user. J Clin Pathol 2002; 55: 141-142.
41. HPA. Clostridium histolyticum in injecting drug users. Commun Dis Rep CDR Wkly [serial online] 2003; 13 (http://www.hpa.org.uk/cdr). Accessed 18 December 2003.
42. Kimura AC, Higa JI, Levin RM, Vigia DC. Necrotising fasciitis and Clostridium sordellii among black tar heroin users. 39th Annual Meeting of the Infectious Diseases Society of America. San Francisco, 25-28 October 2001: 58.
43. Bartlett JG. Gas gangrene (other clostridium associated diseases). In: Mandell GL, Douglas RG, Bennett JE, eds. Principles and practice of injections diseases. New York: Churchill Livingstone, 1851-1860.
44. Ringertz SH, Hoiby EA, Jensenius M, et al. Injectional anthrax in a heroin skin popper. Lancet 2000; 365: 574.
45. Brazier JS, Duerden BI, Hall V, et al. Isolation and identification of Clostridium spp. from infections associated with the injection of drugs: experiences of a microbiological investigation team. J Med Microbiol 2002; 51: 985-989.
46. Passaro DJ, Werner SB, McGee J, Mackenzie WR, Vugia DJ. Wound botulism associated with black tar heroin among injecting drug users. J Am Med Assoc 1998; 279: 859-863.